“Efficacy and Safety of Tralokinumab Plus Concomitant Topical Corticosteroids (TCS) in Adult Patients With Moderate-to-Severe Atopic Dermatitis: Results from the 32-Week, Phase 3 ECZTRA 3 Trial”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 6, Oct. 2020, p. s102, https://doi.org/10.25251/skin.4.supp.102.